TSC2 and lymphangioleiomyomatosis: Through mutations in the TSC1 and TSC2 genes, this inhibitory effect on the mTOR pathway is lost, and that pathway becomes hyperactivated, resulting in the growth, proliferation, and dissemination of LAM cells.17